IBRNvsIWO
iShares Neuroscience and Healthcare ETF against iShares Russell 2000 Growth ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | IWO | |
|---|---|---|
| Expense ratio | 0.47% | 0.24% |
| Assets | $7931.50T | $14.9B |
| Net flow, 1 month | +$2M | −$184M |
| Net flow, 1 year | +$2M | −$657M |
| Return, YTD | +27.9% | +19.3% |
| Return, 1 year | +68.6% | +31.6% |
| Avg daily volume | 3K | 390K |
| Holdings | 54 | 1064 |
| Listed | Aug 23, 2022 | Jul 23, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS